3 Biotech Stocks Under $10 Moving Higher

Threshold Pharmaceuticals

Threshold Pharmaceuticals (THLD) is a biotechnology company focused on the discovery and development of drugs targeting the microenvironment of solid tumors as novel treatments for patients living with cancer. This stock is trading up 3.5% to $4.56 in recent trading.

Today's Range: $4.40-$4.59

52-Week Range: $2.90-$9.28

Volume: 331,000

Three-Month Average Volume: 876,681

From a technical perspective, THLD is bouncing higher here right above some near-term support at $4.36 to $4.28 and back above its 50-day moving average of $4.46 with lighter-than-average volume. This move is quickly pushing shares of THLD within range of triggering a near-term breakout trade. That trade will hit if THLD manages to take out some near-term overhead resistance levels at $4.75 to $4.80 with high volume.

Traders should now look for long-biased trades in THLD as long as it's trending above $4.36 to $4.28, and then once it sustains a move or close above those breakout levels with volume that hits near or above 876,681 shares. If that breakout triggers soon, then THLD will set up to re-test or possibly take out its next major overhead resistance levels at $5.54 to its 200-day moving average at $6.08.

Keryx Biopharmaceuticals

Keryx Biopharmaceuticals (KERX) is a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease. This stock is trading up 5.8% to $7.01 in recent trading.

Today's Range: $6.56-$7.35

52-Week Range: $1.28-$9.98

Volume: 10.18 million

Three-Month Average Volume: 6.38 million

From a technical perspective, KERX is spiking higher here right off some near-term support at $6.55 to $6.50 with monster upside volume. This move is coming after shares of KERX recently sold off from its high of $9.98 to around $6.50 with heavy downside volume. Shares of KERX are now quickly moving within range of triggering a near-term breakout trade. That trade will hit if KERX manages to take out some near-term overhead resistance levels at $6.90 to $7.30 and then once it clears more resistance that sits just below $8. At last check, KERX has hit an intraday high of $7.35 and volume is well above its three-month average action of 6.48 million shares.

« First ‹ Previous 1 2 3 Next › Last »